Physician–Patient Discussions of Controversial Cancer Screening Tests Questionnaire

Dunn, Andrew; Shridharani, Kanan V.; Lou, Wendy; Bernstein, Jeffrey I.; Horowitz, Carol R.

doi:10.1037/t40947-000

Cited by 44 publications

(74 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Dunn et al found that providers often do not discuss cancer screening tests with their patients, especially controversial ones, such as prostate cancer screening. Some patients may, thereby, be inappropriately denied the opportunity to choose whether to be screened for prostate cancer [23]. However, the providers in this study report high levels of prostate cancer screening.…”

Section: Discussionmentioning

confidence: 82%

“…According to the Centers for Disease Control [22], colorectal cancer screening is particularly low among immigrants, especially among those who have immigrated within the past 10 years. Culturally competent interventions should be developed and investigated to increase adherence to the colorectal cancer screening guidelines, and immigrant-serving physicians should be enlisted to increase screening [23].…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Cancer Screening and Haitian Immigrants: The Primary Care Provider Factor

Gany

Trinh‐Shevrin

Aragones

2007

J Immigrant Minority Health

View full text Add to dashboard Cite

Background-Haitian immigrants, among the fastest growing immigrant communities in the United States, have low cancer screening rates. Several patient barriers have been identified and associated with low screening rates but little is known on provider barriers for cancer screening. To address this gap, we assessed the cancer screening practices, attitudes, and beliefs of primary care providers serving the Haitian community.

show abstract

Section: Discussionmentioning

confidence: 82%

Section: Discussionmentioning

confidence: 99%

Cancer Screening and Haitian Immigrants: The Primary Care Provider Factor

Gany

Trinh‐Shevrin

Aragones

2007

J Immigrant Minority Health

View full text Add to dashboard Cite

show abstract

“…For example, provider cultural competence 7,13,26,27 and better quality of communication between patients and providers 4,22 are associated with higher CRC screening rates. Similarly, rates are higher with greater patient acculturation 28 and health literacy.…”

Section: Discussionmentioning

confidence: 99%

“…19 Discussion of screening for CRC is complicated and time consuming, and may be omitted or abbreviated when there are language barriers. 22 A recent study showed that patients who spoke Spanish at home were less likely to receive CRC screening compared to patients who spoke English at home, even after controlling for English proficiency and patient characteristics. 23 However, that study did not take into account whether someone at the provider's office spoke the patient's preferred language.…”

Section: Objectivementioning

confidence: 99%

Patient-Provider Language Concordance and Colorectal Cancer Screening

et al. 2010

View full text Add to dashboard Cite

BACKGROUND AND OBJECTIVE: Patient-provider language barriers may play a role in health-care disparities, including obtaining colorectal cancer (CRC) screening. Professional interpreters and language-concordant providers may mitigate these disparities. DESIGN, SUBJECTS, AND MAIN MEASURES:We performed a retrospective cohort study of individuals age 50 years and older who were categorized as EnglishConcordant (spoke English at home, n=21,594); Other Language-Concordant (did not speak English at home but someone at their provider's office spoke their language, n=1,463); or Other Language-Discordant (did not speak English at home and no one at their provider's spoke their language, n=240). Multivariate logistic regression assessed the association of language concordance with colorectal cancer screening. KEY RESULTS: Compared to English speakers, nonEnglish speakers had lower use of colorectal cancer screening (30.7% vs 50.8%; OR, 0.63; 95% CI, 0.51-0.76). Compared to the English-Concordant group, the Language-Discordant group had similar screening (adjusted OR, 0.84; 95% CI, 0.58-1.21), while the Language-Concordant group had lower screening (adjusted OR, 0.57; 95% CI, 0.46-0.71). CONCLUSIONS: Rates of CRC screening are lower in individuals who do not speak English at home compared to those who do. However, the Language-Discordant cohort had similar rates to those with English concordance, while the Language-Concordant cohort had lower rates of CRC screening. This may be due to unmeasured differences among the cohorts in patient, provider, and health care system characteristics. These results suggest that providers should especially promote the importance of CRC screening to non-English speaking patients, but that language barriers do not fully account for CRC screening rate disparities in these populations.

show abstract

“…Women indicate that they desire to be actively involved in decision-making regarding medical testing related to breast health; 19 however, physicians report that they often do not discuss breast cancer screening methods with their patients. 20 Discomfort during exam and the patient's perception of efficacy of CBE have been reported as factors that deter some women from adherence to screening CBE. 21 Discussing the fact that mammogram screening is not perfect and that some tumors may not be detected on mammography may convince more women to be compliant with screening CBE.…”

mentioning

confidence: 99%

The Clinical Breast Exam: A Skill that Should Not Be Abandoned

Bryan

Snyder

2013

J GEN INTERN MED

View full text Add to dashboard Cite

The clinical breast exam (CBE) is an important tool in the care of women. However, the utility of the screening CBE has been called into question. This article discusses the importance of the CBE as a physical diagnosis tool. Recommendations regarding screening with CBE are reviewed, and evidence surrounding breast cancer screening using CBE is briefly summarized. Clinicians should strive to provide high quality CBEs as part of the general clinical exam for women, particularly those who present with breast complaints, and for patients who choose to have CBE screening. In conclusion, there is a role for the CBE in the care of women, and clinicians should be proficient at performing these exams. Simulation teaching technologies are now available at Department of Veteran Affairs (VA) facilities to enable clinicians to improve their CBE skills. T he clinical breast exam (CBE) is an important tool in the care of women. It is utilized for the evaluation of breast complaints and, more controversially, in breast cancer screening. The Department of Veteran Affairs (VA) Women's Health Services Office has recently coordinated the distribution of breast exam simulation equipment to VA facilities in order to enhance CBE competency training for VA providers. Since the utility of the screening CBE has been called into question, 1 the issue may be raised as to whether this training is pertinent. The following summary will provide rationale that the CBE is an important physical diagnosis skill that should not be discarded, and that simulation equipment is a helpful tool in training clinicians.Clearly, the CBE is required for the evaluation of patients with breast complaints, particularly those with a breast lump. In one study of primary care clinics, 11 % of women complaining of a breast lump and 4 % of women with any breast complaint were found to have a malignancy. 2 In addition, a significant number of patients with breast cancer present with a palpable breast mass. Haakinson et al. 3 reported that 34 % of women with invasive breast cancer initially presented with a palpable lesion. 13 % of the women with a palpable breast mass who were found to have invasive cancer had a normal mammogram within the previous year. Likewise, a large study of diagnostic mammograms reported that the sensitivity of mammography in women with a self-reported breast lump was 87.3 %. 4 This suggests that approximately 13 % of clinically evident breast cancers may be missed by mammography imaging. Therefore, identifying these tumors by palpation is a pertinent clinical issue, and providers should be proficient at discerning abnormal breast findings.The more divisive issue is whether the clinical breast exam should be used in conjunction with mammography for breast cancer screening in asymptomatic patients. The US Preventive Services Task Force (USPSTF) states that there is insufficient evidence to recommend for or against routine screening with the CBE. 1 However, the American Cancer Society 5 and the American College of Obstetricians and Gynecologist...

show abstract

Physician–Patient Discussions of Controversial Cancer Screening Tests Questionnaire

Cited by 44 publications

References 0 publications

Cancer Screening and Haitian Immigrants: The Primary Care Provider Factor

Cancer Screening and Haitian Immigrants: The Primary Care Provider Factor

Patient-Provider Language Concordance and Colorectal Cancer Screening

The Clinical Breast Exam: A Skill that Should Not Be Abandoned

Contact Info

Product

Resources

About